LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4
Publication/Presentation Date
6-1-2017
Abstract
Intravenous transfer of LPS-treated bone marrow-derived dendritic cells blocks development of autoimmunity induced by CD4
Volume
65
Issue
3
First Page
630
Last Page
638
ISSN
1559-0755
Published In/Presented At
Zhou, F., Zhang, G. X., & Rostami, A. (2017). LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127. Immunologic research, 65(3), 630–638. https://doi.org/10.1007/s12026-016-8881-z
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27942984
Department(s)
Administration and Leadership
Document Type
Article
COinS